Journals / Turkish archives of otorhinolaryngology / 2021 / Cilt: 59 - Sayı: 2

The Short-Term Effect of Eugenol on the Prevention of Experimentally Induced Myringosclerosis in a Rat Model

Pages
124–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

More studies with different extracts are needed to investigate the efficacy of phytotherapeutic agents for preventing MS development following myringotomy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of our study was to assess the possible short-term effects of topical and oral eugenol on the suppression of experimentally developed myringosclerosis (MS).
📊
Key Findings & Data:The tympanic membranes (TMs) of all subjects were myringotomized, and group 1 was given no treatment (as control group), group 2 received saline, group 3 had received topical eugenol and group 4 received oral eugenol.
💡
Conclusion & Impact:More studies with different extracts are needed to investigate the efficacy of phytotherapeutic agents for preventing MS development following myringotomy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The aim of our study was to assess the possible short-term effects of topical and oral eugenol on the suppression of experimentally developed myringosclerosis (MS). Methods: Four groups of seven male Wistar albino rats were used in the study. The tympanic membranes (TMs) of all subjects were myringotomized, and group 1 was given no treatment (as control group), group 2 received saline, group 3 had received topical eugenol and group 4 received oral eugenol. Results: In macroscopic evaluation the control and saline groups showed much more MS compared to the topical and oral eugenol groups which had statistically significantly less changes (p<0.05). Fibrosis and inflammation regarding the lamina propria (LP) of the eardrums of the topical and oral eugenol groups were significantly less than those of the control and saline groups (p<0.001). In microscopic evaluation, TMs were found to be thicker in the control and saline groups (p<0.001). Conclusion: Our study showed that the application of topical and oral forms of eugenol reduced fibrosis and prevented the advancement of MS in the LP of the TMs in the short-term. More studies with different extracts are needed to investigate the efficacy of phytotherapeutic agents for preventing MS development following myringotomy.

🔖

Cite This Article

EGILMEZ, O. K., GÜVEN, M., ELDEN, S. G., BUDAK, Ö., ÇAKIROĞLU, H., ELDEN, H., GÜVEN, E. M. (2021). The Short-Term Effect of Eugenol on the Prevention of Experimentally Induced Myringosclerosis in a Rat Model. Turkish archives of otorhinolaryngology, Cilt: 59 - Sayı: 2, 124–132. https://ajindex.com/articles/403327

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kargin Kaytez S, Kavuzlu A, Yumusak N, Oçal R, Akkoca O. Is there any effect of montelukast on prevention of myringosclerosis after myringotomy in a rat model? Eur Arch Otorhinolaryngol 2019
  2. [Crossref] 2. Eğilmez OK, Kökten N, Ekici AI, Kalcıoğlu MT, Yesilada E, Tekin M. The effect of Hypericum perforatum L. (St. John’s Wort) on prevention of myringosclerosis after myringotomy in a rat model. Int J Pediatr Otorhinolaryngol 2015
  3. [Crossref] 3. Zielnik-Jurkiewicz B, Olszewska-Sosińska O, Rakowska M. [Results of treatment with tympanostomy tubes in children with otitis media with effusion] (Article in Polish). Otolaryngol Pol 2006
  4. [Crossref] 4. Slack RW, Maw AR, Capper JW, Kelly S. Prospective study of tympanosclerosis developing after grommet insertion. J Laryngol Otol 1984
  5. [Crossref] 5. Asiri S, Hasham A, al Anazy F, Zakzouk S, Banjar A. Tympanosclerosis: review of literature and incidence among patients with middle-ear infection. J Laryngol Otol 1999
  6. [Crossref] 6. Üstündağ M, Koçyiğit M, Bulut E, Altaner Ş, Taş A, Yağız R. Effect of topical dexamethasone for preventing experimentally induced myringosclerosis. Turk Arch Otorhinolaryngol 2017
  7. [Crossref] 7. Song JJ, Kwon SK, Cho CG, Park SW. The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 2007
  8. [Crossref] 8. Dogan E, Erdag TK, Sarioglu S, Ecevit MC, Ikiz AO, Güneri EA. The preventive effect of N-nitro L-arginine methyl ester in experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 2011
  9. [Crossref] 9. Özdemir D, Ağrı İ, Bakirtaş M, Ağrı A, Mehel DM, Çelebi M, et al. The effect of rosmarinic acid on the prevention of myringosclerosis. Int J Pediatr Otorhinolaryngol 2019
  10. 109597. [Crossref] 10. Kokten N, Egilmez OK, Dogan Ekici AI, Kalcioglu MT, Tekin M, Yesilada E. The effect of Nigella sativa oil on prevention of myringosclerosis in a Guinea pig model. Int J Pediatr Otorhinolaryngol 2016
  11. [Crossref] 11. Nejad SM, Özgüneş H, Başaran N. Pharmacological and toxicological properties of eugenol. Turk J Pharm Sci 2017
  12. [Crossref] 12. Sakat MS, Kilic K, Akdemir FNE, Yildirim S, Eser G, Kiziltunc A. The effectiveness of eugenol against cisplatin-induced ototoxicity. Braz J Otorhinolaryngol 2019
  13. [Crossref] 13. National Toxicology Program. Carcinogenesis studies of eugenol (C